For the quarter ended December 2025, Encompass Health (EHC) reported revenue of $1.54 billion, up 9.9% over the same period last year. EPS came in at $1.46, compared to $1.17 in the year-ago quarter.
The reported revenue represents a surprise of +0.23% over the Zacks Consensus Estimate of $1.54 billion. With the consensus EPS estimate being $1.29, the EPS surprise was +12.95%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Encompass Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Net patient revenue per discharge: $22,273.00 versus $22,062.08 estimated by two analysts on average.
- Discharges: 67,238 versus 67,407 estimated by two analysts on average.
- Net Operating Revenues- Net patient revenue- Inpatient: $1.5 billion versus $1.49 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +9.6% change.
View all Key Company Metrics for Encompass Health here>>>
Shares of Encompass Health have returned -10.1% over the past month versus the Zacks S&P 500 composite's +0.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Encompass Health Corporation (EHC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
